Ikonisys S.A.
ALIKO.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$22.11M
Close$
Share Statistics
| Market cap | $22.11 Million |
|---|---|
| Enterprise Value | $24.56 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.3 |
| Beta | 0.69 |
| Outstanding Shares | 15,825,785 |
Return
| Return on Equity | -38.91% |
|---|---|
| Return on Assets | -27.86% |
| Return on Invested Capital | -33.45% |
Valuation & Multiples
| P/E Ratio | -5.13 |
|---|---|
| PEG | -7.02 |
| Price to Sales | - |
| Price to Book Ratio | 1.43 |
| Enterprise Value to Revenue | 10.23 |
| Enterprise Value to EBIT | -3.47 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
October 23, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$758,424
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Ikonisys S.A.
15 employees
CEO: Francesco Trisolini Based in Paris, France, Ikonisys S.A. is a company specializing in cell-based diagnostics. It develops, produces, and commercializes medical diagnostic solutions for various cancers across the United States and Europe. Their core offerin...